
Bill Ackman buys Second Beresford unit for $13.5 Million
Pershing Square founder Bill Ackman, purchased the second apartment at the iconic Beresford building at 211 Central Park West, for $13.5 million or $4,632 per square foot, according to The Real Deal, citing More...

Bill Ackman sells disastrous stake in Valeant at huge loss
In dramatic step, finally, billionaire hedge fund Bill Ackman on Monday threw in the towel on Valeant pharmaceuticals, investment he made three years ago. In all, the loss totals nearly $4 billion, Forbes reported. Not More...

Bill Ackman Releases 18th Video crusade against Herbalife after $1Billion hit
Bill Ackman’s Pershing Square continues his almost four years crusade against Herbalife. The hedge funed released its 18th video on Thursday warning investors about the alleged the company is More...

Bill Ackman’s Pershing Square Sells $835 Million in Mondelez Shares
Bill Ackman’s said he sold nearly $835 million in shares of the snack food maker Mondelez. The announcement comes one day after Ackman’s hedge fund Pershing Square’s investment in Valeant More...

Bill Ackman’s hedge fund sues CWCapital for $500 Million over Stuy Town
Pershing Square Capital Management and Winthrop Realty Trust are suing CWCapital for $500 million, claiming they got bilked out of a fat profit when the special servicer foreclosed on Stuyvesant Town-Peter More...

Valeant, Ackman must face U.S. insider trading lawsuit
A U.S. judge said Valeant Pharmaceuticals International Inc (VRX.TO) (VRX.N) and activist hedge fund manager William Ackman must face a lawsuit accusing them of insider trading in Allergan Inc before More...

Hedge fund manager Bill Ackman grasps 7.5% Mondelez stake
Bill Ackman, the activist hedge fund manager, has put a $5.5 billion bet on Mondelez (7.5 per cent stake), the maker of Oreo, Cadbury’s chocolate and Trident gum, in an attempt to force the food More...

Three Way Takeover Battle: Teva set to buy Allergan’s generics unit – WSJ
Teva likely mean the end of Teva’s pursuit of another Teva Pharmaceutical Industries Ltd. likely mean the end of pursuit of Mylan acquisition. The Israeli world’s biggest generic pharmaceutical maker More...

Cash-Strapped Ackman Might Back Off from Activism …. for Now
In the annals of activist investing, 2014 was the year of Bill Ackman, but lacking enough dry powder, he might not be firing as much in 2015, according to the New York Post. Ackman’s many battles earned More...

Bill Ackman Not Likely to Plunk Down Cash Hoard Anytime Soon
The comparatively low level of cash assets currently held by hedge fund mogul Bill Ackman probably means that he won’t be making any activist investments for the next few months. Ackman’s $18.3 billion Pershing More...